Search

Your search keyword '"Jane S. Lebkowski"' showing total 78 results

Search Constraints

Start Over You searched for: Author "Jane S. Lebkowski" Remove constraint Author: "Jane S. Lebkowski"
78 results on '"Jane S. Lebkowski"'

Search Results

1. Microcarrier-Based Culture of Human Pluripotent Stem-Cell-Derived Retinal Pigmented Epithelium

2. Ten-year safety of pluripotent stem cell transplantation in acute thoracic spinal cord injury

3. A phase 1/2a dose-escalation study of oligodendrocyte progenitor cells in individuals with subacute cervical spinal cord injury

4. Safety of direct injection of oligodendrocyte progenitor cells into the spinal cord of uninjured Göttingen minipigs

5. Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitor Cells: Preclinical Efficacy and Safety in Cervical Spinal Cord Injury

6. Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia

7. Preclinical safety of human embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in spinal cord injury

8. Immune responses and long-term disease recurrence status after telomerase-based dendritic cell immunotherapy in patients with acute myeloid leukemia

9. Generation of immunogenic dendritic cells from human embryonic stem cells without serum and feeder cells

10. Modification of human embryonic stem cell-derived dendritic cells with mRNA for efficient antigen presentation and enhanced potency

11. Direct Differentiation of Human Embryonic Stem Cells to Hepatocyte-like Cells Exhibiting Functional Activities

12. Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines

13. Expansion of human embryonic stem cells in defined serum‐free medium devoid of animal‐derived products

14. Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity

15. GRNOPC1: the world’s first embryonic stem cell-derived therapy

16. Response to Frederic Bretzner et al. 'Target Populations for First-In-Human Embryonic Stem Cell Research in Spinal Cord Injury'

17. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters

18. Dendritic Cells Loaded With MART-1 Peptide or Infected With Adenoviral Construct Are Functionally Equivalent in the Induction of Tumor-Specific Cytotoxic T Lymphocyte Responses in Patients With Melanoma

19. Interview: Discussions on the development of human embryonic stem cell-based therapies

20. Telomerase: A Target for Anticancer Therapy

21. Animal Serum-Free Culture of Purified Human CD34+ Cells: Amplification of Progenitors from G-CSF and GM-CSF-Mobilized Peripheral Blood

22. Breast Cancer: Cell and Gene Therapy

23. Transient protection of human T-cells from human immunodeficiency virus type 1 infection by transduction with adeno-associated viral vectors which express RNA decoys

24. Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice

25. RETENTION OF ENDOCRINE FUNCTION IN THE SCID-Hu PANCREAS MOUSE—A MODEL FOR THE DEVELOPMENT OF HUMAN FETAL ISLET TISSUE

26. 276. Long-Term Relapse-Free Survival of Patients with Acute Myeloid Leukemia (AML) Receiving a Telomerase-Engineered Dendritic Cell Immunotherapy

27. Separation of Lectin-Binding Cells Using Polystyrene Culture Devices with Covalently Immobilized Soybean Agglutinin

28. Differentiation of Dendritic Cells from Human Embryonic Stem Cells

29. Differential expression of human nicotinic acetylcholine receptor α subunit variants in muscle and non-muscle tissues

30. Human Umbilical Cord Blood CD34+Cell Purification with High Yield of Early Progenitors

31. Growth and differentiation of human embryonic stem cells for cardiac cell replacement therapy

32. ENRICHMENT OF MURINE HEMATOPOIETIC STEM CELLS

33. Immunological properties of human embryonic stem cell-derived oligodendrocyte progenitor cells

34. Long-term follow-up of patients with acute myelogenous leukemia receiving an autologous telomerase-based dendritic cell vaccine

35. 222. AST-VAC2: An Embryonic Stem Cell-Derived Dendritic Cell Cancer Immunotherapy

36. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes

37. Basic fibroblast growth factor supports undifferentiated human embryonic stem cell growth without conditioned medium

38. Monitoring early differentiation events in human embryonic stem cells by massively parallel signature sequencing and expressed sequence tag scan

40. Immortalized fibroblast-like cells derived from human embryonic stem cells support undifferentiated cell growth

41. Serum-free derivation of human embryonic stem cell lines on human placental fibroblast feeders

42. MPSS profiling of human embryonic stem cells

43. Human embryonic stem cells possess immune-privileged properties

44. Enhanced long-term survival, but no increase in replicative capacity, following retroviral transduction of human cord blood CD34+ cells with human telomerase reverse transcriptase

45. Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation

46. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells

48. Ligand-mediated cytolysis of tumor cells: use of heregulin-zeta chimeras to redirect cytotoxic T lymphocytes

49. Cytotoxic T lymphocytes from humans with adenocarcinomas stimulated by native MUC1 mucin and a mucin peptide mutated at a glycosylation site

50. Correction

Catalog

Books, media, physical & digital resources